We demonstrated that, following treatment with chemotherapeutics, MDM2 is released from the MRN complex in an ATP-dependent reaction, triggering efficient homologous recombination DNA repair, thereby allowing cancer cells to survive the exposure to DNA-damaging drugs. Here, MDM2 is linked to cancer.